The new facility which was to be located on an 11-acre site in Durham, NC was planned to be an FDA-regulated commercial launch site for their precision immunotherapy product AGS-003 to combat metastatic renal cell carcinoma. The facility was planned to consist of cleanroom space for manufacturing and fill-finish, quality control labs, cGMP warehouse, shipping/receiving, and administration with a total programmed space of 124,500 SF. The Center Pointe facility would have provided Argos scale-out capabilities to increase their overall throughput over the years. The facility was designed to support commercial launches of other personalized immunotherapies using their proprietary Arcelis™ platform.
As the Construction Manager for this project, we were responsible for establishing and implementing project controls including budget, schedule, quality, information flow, and maintaining project objectives. During pre-construction, we facilitated the selection of the design and general contractor team and performed feasibility studies during site selection.